TNF and cancer: Figure 4B shows that combination therapy to treat glioblastoma involves the pathways mainly enriched in proteoglycans in cancer, the tumor necrosis factor (TNF) signaling pathway, microRNA in cancer and pathways in cancer, among which the proteoglycans in cancer pathway had the smallest p value (Table 2).